期刊文献+

中成药重复用药的精细化设置在门诊前置审核中的应用实践

Application practice of refined setting of repeated medication of Chinese patent medicine in outpatient pre-audit
原文传递
导出
摘要 目的:改善处方前置审核系统对中成药重复用药处方的审核适用性,提高中成药处方审核质量和合理用药水平。方法:通过处方前置审核系统获取许昌市中心医院2022年8月1日至10月31日门诊中成药重复用药不合理问题清单,以循证医学证据为基础,建立明确、科学、统一的审核标准,并以此构建中成药重复用药审核数据库,进一步完善前置审方中成药规则库,评价精细化设置后的效果。结果:经过1个月(2022年11月)规则库的持续修订与完善,门诊中成药重复用药任务数占比从6.31%降至1.73%(χ^(2)=1178.95,P<0.01),系统拦截率从1.05%增加到3.23%(χ^(2)=363.53,P<0.01),系统审核后医生修改率从36.68%提升到53.31%(χ^(2)=525.69,P<0.01),药师审核率从3.14%下降到2.55%(χ^(2)=24.04,P<0.01),平均单张处方金额从(128.5±13.59)元降低到(112.86±11.46)元(t=4.899,P<0.01),差异均有统计学意义。结论:审核规则的精细化设置能有效弥补现有审核系统对中成药重复用药审核的不足,改善审方系统对中成药重复用药处方的审核适用性,显著提高门诊中成药的处方质量,对保障门诊中成药应用安全性、提升药学服务质量具有重要的意义。 OBJECTIVE To improve the applicability of pre-prescription audit system for reviewing repeated prescriptions of Chinese patent medicine and enhance the quality of prescription audit and the level of rational drug use.METHODS Through the pre-prescription audit system,the list of irrational repeated use of Chinese patent medicines at outpatient clinics of Xuchang Cen⁃tral Hospital from October 1 to October 31,2022 was compiled.Based upon evidence-based medical evidence,a definite,scien⁃tific and unified audit standard was established.And a database of repeated use of Chinese patent medicines was constructed for fur⁃ther refining the rule base of pre-prescription Chinese patent medicines and evaluating the effect of refined setting.RESULTS After refining the audit rules,the proportion of repeated drug dosing tasks in outpatient Chinese patent medicines dropped from 6.31%to 1.73%(χ^(2)=1178.95,P<0.01),system interception rate spiked from 1.05%to 3.23%(χ^(2)=363.53,P<0.01),phy⁃sician modification rate jumped from 36.68%to 53.31%(χ^(2)=525.69,P<0.01),and pharmacistaudit rate declined from 3.14%to 2.55%(χ^(2)=24.04,P<0.01).Average amount of single prescription decreased from(128.5±13.59)yuan to(112.86±11.46)yuan(t=4.899,P<0.01),and the difference was statistically significant.CONCLUSION Fine-tuning of audit rules can effectively make up for the shortcomings of existing audit system for repeated use of Chinese patent medicines,improve the appli⁃cability of audit system for repeated use of Chinese patent medicines and significantly enhance the prescription quality of outpatient Chinese patent medicines.It is imperative to ensure the safety of outpatient Chinese patent medicines and boost the quality of phar⁃maceutical services.
作者 张慧丽 田京辉 徐贞贞 曹凯 徐炳欣 赵亮 ZHANG Huili;TIAN Jinghui;XU Zhenzhen;CAO Kai;XU Bingxin;ZHAO Liang(Department of Phar-macy,Xuchang Central Hospital,Henan Xuchang 461000,China)
出处 《中国医院药学杂志》 CAS 北大核心 2024年第11期1345-1350,共6页 Chinese Journal of Hospital Pharmacy
基金 许昌市科学技术局市级重点研发与推广专项(编号:20220213038) 许昌市重点研究与推广项目(编号:20230213068)。
关键词 中成药 重复用药 药味组成 处方前置审核系统 合理用药 Chinese patent medicine repeated medication medicinal composition prescription pre-audit system rational drug use
  • 相关文献

参考文献13

二级参考文献213

共引文献312

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部